New treatment suggests that intensive glucose-lowering treatment for those with type 2 diabetes does not lower the likelihood of death related to heart disease and GPs ought to be careful when prescribing such a treatment .
Type 2 diabetics have a higher risk of cardiovascular disease .
Intensive glucose-lowering treatment is used widely for such patients although prior research has not illustrated any set benefits.
A review was undertaken of 13 studies which included 34,533 diabetics; 18,315 had had intensive glucose-lowering treatment and 16,218 had had standard treatment.
The researchers found that Intensive treatment did not considerably lower cardiovascular death, however, it was related to a 15 percent lower risk of non-fatal heart attacks and a 10 percent lower risk of microalbuminuria, an indicator of kidney problems and heart disease .
Intensive Treatment of Type Two Diabetics does not Lower Risk of Heart Disease
Mon, 01 Aug 2011
Recommended linksDiabetic Travel Insurance Quote
Holiday Travel Insurance
Equipment You Need to Take Abroad
Dealing with Holiday Illness
Long Haul Flights
Diabetes Travel News
Coffee Demonstrated to Lower Risk of Diabetes
Breast Feeding Lowers Risk of Diabetes for Mums
Cabbage and Spinach Could Lower Risk of Developing Type 2 Diabetes
Healing Times Lower for Diabetics worse with Depression
Child Fitness Levels Lower in Affluent Areas
Weight Loss Helps Lower Chance of Developing Diabetes
A Healthier Lifestyle Lowers Chances of Chronic Diseases
Heating up tumours could improve cancer treatment
Nestle In Development of Products for Treatment of Diabetes and Obesity
Diabetes Treatment Shows Mixed Results
Research Shows New Treatment Effective for Vision Loss in Diabetics
Treatment for Gum Disease Could Help Disease
Common Drug for Diabetes Can Help Cancer Treatment
BA Condemned for Mistreatment of the Sick
New study finds lowering blood sugar may not be best course for type 2 diabetes
Warning about use of fibrates for lowering cholesterol
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes